Monitoring Agency Report for the Quarter Ended March 31, 2025.
VLEGOV · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
CARE Ratings, acting as Monitoring Agency, has filed its report on the company's preferential issue of share warrants. The issue was undersubscribed: only Rs. 400.99 crore was raised against the planned Rs. 630 crore, with the company scaling down all object categories accordingly (e-Governance projects cut from Rs. 50 cr to Rs. 30 cr, expansion from Rs. 100 cr to Rs. 50 cr, etc.). During Q4 FY25, the company raised Rs. 114.31 crore and used Rs. 70.22 crore — mostly Rs. 67.21 crore went to repaying unsecured loans to related parties Vakrangee Limited (Rs. 16.12 cr) and Vakrangee Finserve Limited (Rs. 51.09 cr), with Rs. 3.01 crore for general corporate purposes. The remaining Rs. 44.09 crore is parked in fixed deposits with Kotak, SBI, and Union Bank earning 7.30-7.50%. The report flags several concerns: large vendor advances of Rs. 1,327.57 crore, trade receivables of Rs. 1,159.12 crore (Rs. 811 cr overdue over 3 years), a Rs. 162.30 crore contractual assets write-off in FY24, promoter shareholding dilution from 33.16% to 23.24%, the death of promoter Dinesh Nandwana and subsequent board changes, and a share price decline of 75% from peak with the current Rs. 48.45 price well below the Rs. 75 warrant exercise price.
There is no formal deviation from stated objects, but the heavy use of raised funds to repay related-party loans, large sticky receivables, vendor advances, promoter dilution, leadership transition, and a share price trading below the warrant exercise price are red flags that may concern retail investors. The undersubscription means growth and expansion plans are scaled back, potentially limiting future upside.